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Background: Atherosclerosis is a chronically inflammatory disease and one of the
leading causes of deaths worldwide. Endothelial cell apoptosis plays a crucial role in its
development. Several microRNAs (miRNAs) are reportedly involved in atherosclerotic
plaque formation, including miRNA-210 (miR-210). However, the underlying mechanism
of its role in endothelial cell apoptosis during atherosclerosis is still largely unknown.
Methods: A mouse model with atherosclerosis induced by a high-fat diet (HFD) was
built in ApoE (-/-) mice. The levels of endothelial cell apoptosis were determined via
flow cytometry. The expressions of miR-210 and PDK1 in purified CD31+ endothelial
cells from mouse aorta were measured via RT-qPCR and western blot. Binding between
miR-210 and the 3′-untranslated region (UTR) of PDK1 mRNA was predicted using
bioinformatics analyses and confirmed with a dual luciferase reporter assay. The effects
of miR-210 were further analyzed in an in vitro model using human aortic endothelial
cells (HAECs) treated with oxidized low-density lipoprotein (ox-LDL).
Results: We found that the HFD mice developed atherosclerosis in 12 weeks and had a
significantly higher percentage of endothelial cell apoptosis. The upregulated level of
miR-210 in the HFD mice and HAECs inversely correlated with the level of PDK1.
Inhibiting miR-210 expression significantly reduced HAEC apoptosis, as evidenced by
the results of the MTT and flow cytometry experiments. Further analysis identified PDK1
as the target of miR-210 and showed that PDK1 overexpression reversed the pro-
apoptotic effect of miR-210 through mediation of the P13K/Akt/mTOR pathways.
Conclusion: Our study suggests a novel role for miR-210 in the progression of
atherosclerosis through the regulation of endothelial apoptosis. This indicates that
miR-210 might have potential in treatment of atherosclerosis.
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Atherosclerosis, which is an inflammatory disease and a predominant cause of cardio-
vascular disorders, is a worldwide issue due to the prevalence of diets high in saturated
fats and lipids [1, 2]. In the large arteries, atherogenic lipoproteins, especially low-
density lipoprotein (LDL) cholesterol, build up to gradually form atherosclerotic
plaques, which have been proven to be involved in atherosclerosis-related morbidity [3, 4].
Apolipoprotein E (ApoE) is a 34-kDa secreted protein that has been shown to have
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crucial role of ApoE in protection from atherosclerosis [8]. ApoE (-/-) mice fed with
high-fat diets (HFD) display high lipid levels, excessive cholesterol in the blood vessels
and atherosclerotic symptoms [9], making this an acknowledged model for investigating
atherosclerosis [10].
The endothelium functions as an effective mediator to regulate the vascular system,
with roles in processes such as hemostasis, cell cholesterol, hormone trafficking,
signal transduction and inflammation [11, 12]. Convincing evidence indicates that
dysfunction of the endothelium is associated with various vascular diseases, including
diabetes mellitus, arterial thrombosis and hypercholesterolemia [13]. Endothelial cell
(EC) apoptosis and death can destroy the structure of plaques, and result in the
deposition of local lipids and finally in atherogenesis [14, 15]. Preventing EC apoptosis
has garnered considerable attention as a novel means of treating atherosclerosis [16, 17].
MicroRNAs (miRNAs), are small (18–22 nucleotides) noncoding RNAs that regulate
gene expression by the binding of the 3′-untranslated regions (3′-UTR) of target genes
post-transcriptionally, this suppresses gene expression [18]. Emerging evidence suggests
that miRNAs could be effective therapeutic targets for complex human diseases, in-
cluding tumorgenesis, lymphopoiesis and angiogenesis [19–21].
Preclinical studies have shown that miRNAs also play pivotal roles in the patho-
genesis of atherosclerosis [22, 23]. A recent study showed overexpression of miR-
210 in the serum samples of patients with arteriosclerosis obliterans [24].
Raitoharju et al. further demonstrated that miR-210 was upregulated in human
atherosclerotic plaques and might be involved in the process of atherosclerosis
[25]. However, the regulatory mechanism for miR-210 in the setting of atheroscler-
osis remains unclear.
In this study, we found that miR-210 was upregulated by directly targeting 3-
phosphoinositide-dependent protein kinase-1 (PDK1) in vascular endothelial cells
in an atherosclerosis mouse model and in human aortic endothelial cells (HAECs)
treated with oxidized low-density lipoprotein (ox-LDL). Repression of PDK1 due to
miR-210 upregulation was found to critically contribute to endothelial apoptosis in
the setting of atherosclerosis. Our findings also showed that PDK1 is an essential
miR-210 target in regulating endothelial apoptosis of atherosclerosis by inhibiting
P13K/Akt/mTOR signaling activation. This study demonstrates that inhibiting miR-
210 expression in endothelial cells may be a promising therapeutic approach for
vascular diseases such as atherosclerosis.Methods
Animal models and quantification of atherosclerotic lesions
All experimental procedures were performed according to the guidelines for the Care and
Use of Laboratory Animals of Jilin University, Changchun, China. Male 6-week old ApoE
(-/-) mice were obtained from the Animal Center of Jilin University and housed under
pathogen-free animal room conditions with a 12 h light and dark cycle and a controlled
temperature of 25 °C. The animals were randomly divided into two groups of 10, with the
control group fed a normal chow diet (NOR group) and the experimental group main-
tained on a high-fat diet (HFD) for 12 weeks to induce atherosclerosis (HFD group). After
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ately fixed with 4% paraformaldehyde, embedded in an optimum cutting temperature
(OCT) compound, and cut into 7 μm thick cross-sections.
H&E staining was used to examine the atherosclerotic lesions of the aortic root. The
number of lesions in each cross-section was counted using the grid on the microscope
eyepiece (20 × 20 μm). The length of a lesion along the aortic perimeter and the average
thickness were determined and multiplied to obtain a cross-sectional area in μm2.
The lipid deposition was stained with an Oil Red O staining kit (Sigma-Aldrich) according
to the manufacturer’s instructions and observed through an Olympus reverse microscope.
Briefly, the cross-sections of aortic sinuses (7 μm) were fixed with 4% paraformaldehyde,
and then stained with Oil Red O. The lipid deposits in the plaques were stained red. The
total lesion area was quantified in each group using computer-assisted quantitative analysis
(ImageJ).RNA isolation and quantitative RT-PCR
Total RNA was isolated from CD31+ endothelial cells. After washing with ice-cold PBS, the
aorta was removed and flushed with TRIzol reagent (Invitrogen) using an insulin syringe.
The eluate was collected in a 1.5 ml tube and prepared for RNA extraction. Total RNA and
miRNA were extracted from tissue or cultured cells with RNeasy and miRNeasy Mini kits
(Qiagen), respectively. Complementary DNA (cDNA) was synthesized from the extracted
RNA using a High-Capacity cDNA Reverse Transcription kit (Applied Biosystems). RT-
qPCR was subsequently performed in triplicate with a SYBR Green PCR Kit (Takara Bio) to
quantify the mRNA and miRNA. U6 and GAPDH were used as internal controls to
normalize miRNA and mRNA expressions, respectively. The primers for miR-210 detection
were designed by Genechem Co., Ltd. The 2-△△Ct method was applied to analyze the relative
mRNA expression levels. The sequences of primers were: PDK1 forward: 5′-AGGCAAAG-
GAAGTCCATCTCA-3′, reverse: 5′-CCCATGCATTTGTGCCTACC-3′; GAPDH forward:
5′-CCCATGTTCGTCATGGGTGT-3′, reverse: 5′-CCCATTCCCCAGCTCTCATA-3′.Cell culture and transfection
Normal human aortic endothelial cells (HAECs) were obtained from the American
Type Culture Collection (ATCC) and cultured in endothelial cell medium supple-
mented with endothelial cell growth factors, 5% fetal bovine serum (FBS; Invitrogen)
and 1% penicillin/streptomycin (Invitrogen). The cells were maintained at 37 °C with
5% CO2. To disturb miRNA expression, HAECs were transiently transfected with miR-
210 mimics, miR-210 inhibitors or null controls (Genechem) using Lipofectamine 2000
reagent (Invitrogen) according to the manufacturer’s instructions. To upregulate PDK1
expression, PDK1-overexpressing plasmid was synthesized at Genechem and trans-
fected into HAECs using Lipofectamine 2000. At a point 24 h post-transfection, the
cells were treated with or without 50 μg/ml oxidized low-density lipoprotein (ox-LDL,
Solarbio Bio-Technolgy) for a further 24 h.Cell viability assay
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was
performed to evaluate the cell viability of HAECs. Cells were seeded in 96-well plates
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microlitre of MTT solution (5 mg/ml; Sigma-Aldrich) was added to each well and incu-
bated for 4 h at 37 °C. One-hundred-fifty microlitre of dimethyl sulfoxide (DMSO) was
added to dissolve the formazan crystals. Absorbance at 570 nm was measured using a
microplate reader (ThermoFisher).Western blotting
The cells were harvested and lysed with RIPA buffer containing protease and phos-
phase inhibitors (Sigma-Aldrich). After centrifugation at 12,000 rpm for 10 min at 4 °C,
the supernatants were collected and quantified using the Bradford assay (Bio-Rad). The
proteins were then separated using SDS-PAGE and transfected to PVDF membranes
(Bio-Rad). After blocking with 5% non-fat milk for 1 h at room temperature, the mem-
branes were incubated with primary antibodies, including anti-PDK1 (ab110025;
Abcam), anti-p-Akt (ab38449), anti-Akt (ab32505), anti-p-mTOR (ab109268), anti-Bcl2
(ab692), anti-caspase 3 (ab32351), anti-caspase 9 (ab32539), and anti-GAPDH (ab8245)
followed by incubation with the secondary HRP-conjugated antibody (Cell Signaling).
The bands were scanned using an enhanced chemiluminescence system and protein in-
tensity was quantified with Image-Pro Plus 6.0 software (Media Cybernetics). GAPDH
was used as the internal control.Flow cytometry
For isolation of cells bearing the endothelial cell marker CD31+, the aorta was dissoci-
ated with 10 μg/ml trypsin (Sigma-Aldrich) and 2.5 mg/ml collagenase II for 35 min.
The dissociated single cells were incubated with PE-cy7-CD31 (Becton-Dickinson
Biosciences) and then sorted on a FACScan flow cytometer (Becton-Dickinson Biosci-
ences). The CD31+ cells or cultured cells were re-suspended and double stained with
FITC-Annexin V and propidium iodide (PI) from a FITC Annexin V Apoptosis Detec-
tion Kit I (Becton-Dicknson Biosciences), and cell apoptosis was analyzed using a
FACScan flow cytometer equipped with Cell Quest software (Becton-Dickinson
Biosciences).Luciferase reporter assay
miRNA targets were predicted using algorithms (including PicTar, Target Scan, micro-
RNA). The wild-type and mutant 3′-UTR of PDK1 reporter plasmids were purchased
from Genechem. HAECs were seeded in a 24-well plate and co-transfected with 0.5 μg
plasmid and miR-210 mimics or miR-210 inhibitors or negative controls using Lipofec-
tamine 2000 reagent. Renilla luciferase was used as an internal control. At a point 48 h
post-transfection, the cells were harvested and a Dual-Luciferase Reporter Assay
System Gene Assay Kit (Promega) was used to evaluate the relative luciferase activities
according to the manufacturer’s instructions.Statistical analyses
The data in this study are shown as the means ± standard deviation (SD) and analyzed
using GraphPad Prism 5.0 (GraphPad Software). Statistical differences between the dif-
ferent groups were calculated using Student’s t-test. The correlation of miR-210 and
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was considered statistically significant. Each experiment was performed at least 3 times.Results
HFD induces atherosclerosis in ApoE (-/-) mice
The HFD group ApoE (-/-) mice spent 12 weeks on a high-fat diet (HFD) while the
NOR group ApoE (-/-) mice received a normal diet. As shown in Fig. 1a and b, analysis of
H&E- and Oil Red O-stained histological sections of the aortic sinus revealed that athero-
sclerotic lesions and lipid content were significantly higher in the HFD group (p < 0.05)
than in the NOR group, suggesting that the HFD successfully induced atherosclerosis in
ApoE (-/-) mice. To analyze endothelial cell apoptosis in ApoE (-/-) mice, we dissociated
the mouse aorta and purified endothelial cells based on CD31+ labeling via flow cytome-
try (Fig. 1c).HFD induces endothelial cell apoptosis in ApoE (-/-) mice
The apoptosis rate of CD31+ endothelial cells was assessed via flow cytometry.
The apoptosis assay revealed that HFD significantly increased the percentage of
CD31+ endothelial cell apoptosis in the aorta (Fig. 2a) compared with that in NOR
mice (p < 0.05). Western blot results for CD31+ endothelial cells also showed that
the levels of crucial pro-apoptosis proteins, such as Bax, caspase-9 and caspase-3,
had notably increased, while the level of the anti-apoptosis protein Bcl-2 had
significantly decreased in HFD mice compared to NOR mice (Fig. 2b). These data
indicate that HFD induced endothelial cell apoptosis in the atherosclerosis mouse
model.Fig. 1 HFD-induced atherosclerosis in ApoE (-/-) mice after 12 weeks. a H&E staining and quantification of
the plaque area of the aortic sinus. b Oil Red O staining and quantification of atherosclerotic lesions in the
aortic sinus (lipid deposits stained red). c The CD31+ endothelial cells isolated from aortas using flow
cytometry. n = 10 for each group. *p < 0.05
Fig. 2 HFD induces endothelial cell apoptosis in ApoE (-/-) mice. a The proportions of CD31+ cell apoptosis
were measured using the flow cytometry assay in the HFD and NOR groups. b The protein levels of Bax,
caspase-9, caspase-3 and Bcl-2 in the CD31+ endothelial cells of the HFD and NOR groups were detected
via western blot. c The protein expressions mentioned in (b) were normalized to GAPDH. *p < 0.05
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treated endothelial cells
miR-210 expression in CD31+ cells from ApoE (-/-) mice was examined using RT-qPCR.
As shown in Fig. 3a, a significantly higher expression level of miR-210 was observed in
HFD mice than that in NOR mice (p < 0.01), while the expression level of PDK1 was re-
markably downregulated in HFD mice (p < 0.05). Using Pearson’s coefficient correlation
analysis, a statistically significant inverse correlation (R = −0.738, P = 0.0014) was observed
between the expressions of miR-210 and PDK1 (Fig. 2b).
Oxidized low-density lipoprotein (ox-LDL), a well-known atherogenic factor, was
used to induce endothelial cell apoptosis in this study. HAECs were treated with 0, 25,
50 and 100 ug/ml doses of ox-LDL for 24 h. We found that miR-210 expression was
enhanced by different ox-LDL treatments in HAECs in a dose-dependent manner
(Fig. 2c). To further investigate the effect of ox-LDL on the expression of PDK1, we
measured the mRNA and protein levels of PDK1 in these HAECs. The results showed
downregulation of PDK1 in a dose-dependent manner in HAECs compared to the con-
trol. These data indicate that miR-210 and PDK1 might be involved in endothelial cell
apoptosis in atherosclerosis.PDK1 is a target for miR-210 in HAECs
To understand the mechanisms underlying miR-210 and PDK1 interaction in athero-
sclerosis, we further identified the potential target sites of PDK1 to miR-210 (Fig. 4b).
Firstly, HAECs were transfected with miR-210 mimics, miR-210 inhibitor or Null for
Fig. 3 Abnormal expressions of miR-210 and PDK1 were detected in CD31+ endothelial cells and ox-LDL-treated
endothelial cells. a The expression levels of miR-210 and PDK1 in ApoE (-/-) mice were detected via RT-qPCR.
b The correlation of miR-210 and PDK1 levels in ApoE (-/-) mice was measured via Peason’s coefficient correlation
analysis. The effects of ox-LDL (0, 25, 50 or 100 ug/ml) on miR-210 (c) and PDK1 (d and e) expressions were
detected via RT-qPCR and western blot. *p< 0.05, **p< 0.01
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Then, the wild-type or mutant PDK1-3′UTR vectors were co-transfected with miR-210
mimics or miR-210 inhibitor into HAECs. We found that miR-210 mimics markedly
inhibited the luciferase activity of the wild-type PDK1-3′UTR reporter (p < 0.05),
whereas the miR-210 inhibitor increased luciferase activity compared to the negative
control (p < 0.05) (Fig. 4c). Transfection of miR-210 mimics or miR-210 inhibitor had
no significant effect on the luciferase activity of the mutated PDK1-3′UTR reporter.
To confirm the regulatory effect of miR-210 on PDK1 in HAECs, we examined the
changes in PDK1 protein level following miRNA transfection. Western blot and RT-
qPCR analysis indicated that miR-210 mimics significantly suppressed PDK1 expression
both at the transcriptional and translational levels. This was reversed by transfection of
miR-210 inhibitor (Fig. 4d). These findings suggest that PDK1 expression is directly
regulated by miR-210 in HAECs.MiR-210 promotes endothelial apoptosis by targeting PDK1
The MTT assay was used to assess the effect of miR-210 on endothelial cell survival.
We confirmed that miR-210 mimics significantly decreased the cell viability of ox-LDL-
treated HAECs (p < 0.05), whereas miR-210 inhibitor significantly increased the viable
cell number in ox-LDL-treated HAECs (p < 0.05; Fig. 5a). The flow cytometry assay also
revealed that are markedly increased proportion of cell apoptosis was observed in the
ox-LDL-treated HAECs transfected with miR-210 mimics (p < 0.05), whereas transfec-
tion with the miR-210 inhibitor was sufficient to abolish ox-LDL-induced apoptosis in
ox-LDL-treated HAECs (p < 0.05; Fig. 5b).
A rescue experiment was conducted to validate the crucial role of PDK1 in mediating
the apoptotic action of miR-210 on HAECs. As shown in Fig. 5a, MTT analysis
Fig. 4 PDK1 was a target for miR-210 in HAECs. a miR-210 expression levels in HAECs with miR-210 mimics, miR-
210 inhibitor or null control (Null) transfection were detected via RT-qPCR. b The binding site of miR-210 to the
3′-UTR of PDK1 was calculated through bioinformatics analysis. c Relative luciferase activities with the wild-type or
mutant 3′-UTR of PDK1 were quantified. d The effect of miR-210 on PDK1 expression was examined via qRT-PCR
and western blot. *p< 0.05
Fig. 5 miR-210 promoted endothelial apoptosis by targeting PDK1. a HAECs cell viability was determined using
the MTT assay. b Cell apoptosis of HAECs with different treatments was measured via flow cytometry. c The
protein levels of Bax, caspase-9 and Bcl-2 in HAECs with different treatments were detected via western blot.
*p < 0.05 vs. Null; #p < 0.05 vs. miR-210 mimics
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of miR-210 mimics on HAEC cell viability (p < 0.05, miR-210 + PDK1 vs. miR-210).
Flow cytometry further confirmed that PDK1 overexpression increased the survival
number of ox-LDL-treated HAECs transfected with miR-210 mimics by reducing cell
apoptosis (p < 0.05, miR-210 + PDK1 vs. miR-210; Fig. 5b). Similar regulatory changes
were observed through western blot detection of pro-apoptosis makers (Fig. 5c). These
data suggest that miR-210 promotes ox-LDL-induced apoptosis through down regula-
tion of the expression of PDK1 in HAECs.MiR-210 inhibits P13K/Akt/mTOR signaling activation by targeting PDK1 in
atherosclerosis
It has been well established that PDK1 activates Akt/mTOR signaling in severe cardiac
disease [26]. We were interested in determining the involvement of PDK1 and P13K/
Akt/mTOR signaling in the miR-210 regulatory apoptotic effect in atherosclerosis. The
expressions of key components in P13K/Akt/mTOR signaling were detected in endo-
thelial cells from ApoE (-/-) mice. Western blot results showed that the expression
levels of P13K, p-Akt and p-mTOR significantly decreased in HFD mice compared to
NOR mice, while the total Akt and mTOR expression levels in HFD mice did not
decrease significantly (Fig. 6a). Furthermore, we transfected ox-LDL-treated HAECs
with miR-210 mimic, miR-210 inhibitor, or PDK1-overexpression plasmid. Consistent
with the in vivo tissue result, western blot results showed that miR-210 overexpression
significantly downregulated P13K, p-Akt and p-mTOR expressions, and the mir-210
inhibitor significantly upregulated P13K, p-Akt and p-mTOR expressions, but had no
effect on the total Akt and mTOR protein expressions in ox-LDL treated HAECs
(Fig. 6b). The inhibition of P13K/Akt/mTOR signaling by miR-210 mimics could be
reactivated by PDK1 transfection. Our results suggest that atherosclerosis-associated
endothelial cell apoptosis might result from abundant miR-210 that inhibits P13K/Akt/
mTOR signaling activation by directly targeting PDK1.Discussion
Atherosclerosis is a complex arterial disease characterized by vascular wall inflamma-
tion and atherosclerotic plaque accumulation [1]. Endothelial cells play a critical role in
the development of atherosclerosis, so damage to the vascular endothelium might
increase the risk of triggering the pathogenesis of atherosclerosis [27]. High glucose
and ox-LDL are effective pro-atherosclerotic factors that have been widely applied to
induce apoptosis of endothelial cells in both in vivo and in vitro studies [28, 29].
Though therapeutic improvement of atherosclerosis has been achieved over the past
decade, the prognostic risk is still high in many dyslipidemia patients, which suggests
an urgent for a potent novel therapy [30].
This study demonstrated that aberrant miR-210 expression is involved in the progres-
sion of atherosclerosis via stimulation of endothelial apoptosis in vivo and in vitro. Up-
regulation of miR-210 was associated with increased endothelial cell apoptosis and an
inverse correlation was found between miR-210 and PDK1 mRNA expressions. The
dual-luciferase activity assay further verified that the 3′-UTR of PDK1 was a directly
binding target to miR-210. Overexpression of PDK1 was sufficient to reverse miR-210-
Fig. 6 MiR-210 inhibited P13K/Akt/mTOR signaling activation by targeting PDK1 in atherosclerosis. The
protein levels of P13K/Akt/mTOR signaling in (a) CD31+ endothelial cells of ApoE (-/-) mice and (b)
ox-LDL-treated HAECs were detected via western blot. c A schematic model of miR-210 involved in
atherosclerosis-associated endothelial cell apoptosis. *p < 0.05 vs. Null; #p < 0.05 vs. miR-210 mimics
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nisms involved in the pathology of atherosclerosis: the downstream apoptotic pathway
P13K/Akt/mTOR activation was inhibited by miR-210, as schematically summarized in
Fig. 6c. This study provides convincing evidence that miR-210 might be a potent thera-
peutic target for atherosclerosis.
Recent reports have emphasized that abnormally expressed miRNAs participate in
the mediation of endothelial cell destiny [31]. In fact, miR-210 has been previously
reported to be involved in various cardiovascular diseases. Chen et al. suggested that in-
creased miR-210 expression was found in the aorta of mice with high-fat diets and that
it increased the incidence risks of cardiovascular disease and gastrointestinal cancer
[32]. Zaccagnini et al. reported that miR-210 was a crucial element in the adaptive
mechanism to regulate oxidative metabolism and oxidative stress in the acute periph-
eral ischemia [33]. Zhao et al. proved that serum miR-210 expression was close to the
fetal level in Chinese adult patients with chronic heart failure [34]. Lou et al. indicated
that miR-210 overexpression was associated with the regulation of angiogenesis in
response to ischemic injury to the brain [35]. Li et al. and Raitoharju et al. also demon-
strated that miR-210 was a potential biomarker for diagnosis of atherosclerosis [24, 25].
Our study further identified that the regulatory mechanisms of miR-210 in atheroscler-
osis pertain to the promotion of endothelial apoptosis.
Previous studies have declared that the mechanisms underlying miRNA regulation of
endothelial apoptosis are often attributed to targeting critical genes or the pivotal path-
ways related to apoptosis [36, 37]. Here, we discovered that miR-210 regulated endo-
thelial apoptosis by targeting PDK1. 3-phosphoinositide-dependent protein kinase-1
(PDK1) is a 556-amino acid kinase that possesses a C-terminal pleckstrin homology do-
main [38]. Its character as a potential anticancer target relates to the phosphorylation
of a series of protein kinases, including apoptosis regulatory factor protein kinase B
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physiological processes of cell survival and death [39]. In our study, we found that
reversing PDK1 expression could significantly resist miR-210-induced cell apoptosis in
ox-LDL-treated HAECs, implying an anti-apoptotic role of PDK1 in the development
of atherosclerosis.
Functional analysis also revealed that the activation of the P13K/Akt/mTOR signaling
pathway was notably suppressed by miR-210 in apoptotic endothelial cells, but was
reactivated by exotic PDK1 transfection. The aberrant activation of the P13K/Akt/
mTOR pathway was associated with numerous human disorders [40]. Accumulating
data from biological studies demonstrate that the P13K/Akt/mTOR pathway plays a
prominent role in cell survival, metabolism, growth and proliferation by directly regu-
lating apoptotic proteins such as Bcl-2, caspase-3, caspase-9 and Bax [41, 42].
In ApoE (-/-) mice with HFD-induced atherosclerosis, the elevated expression of pro-
apoptosis factors caspase-3, caspase-9 and Bax and the decreased level of anti-
apoptosis factor Bcl-2 were induced by miR-210 overexpression. Effect of caspases and
Bcl-2/Bax involvement contributes to the initiation of the mitochondrial pathway of
apoptosis [43, 44]. These findings might account for the severe cell death levels in
atherosclerosis.
Conclusions
Our study identified the pro-atherosclerotic role of miR-210 by promoting endothelial
apoptosis partially through targeting PDK1 to suppress the P13K/Akt/mTOR signaling
pathway, providing new insight into the treatment of atherosclerosis.
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